A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

semaglutide

Oral administration once daily alone or together with oral contraceptive.

DRUG

SNAC

Oral administration once daily together with oral contraceptive.

DRUG

Microgynon®

Oral administration once daily alone or together with oral semaglutide or SNAC.

Trial Locations (1)

Novo Nordisk Investigational Site, Berlin